Cargando…
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
Numerous clinical trials are utilizing mesenchymal stem cells (MSC) to treat critical limb ischemia, primarily for their ability to secrete signals that promote revascularization. These cells have demonstrated clinical safety, but their efficacy has been limited, possibly because these paracrine sig...
Autores principales: | Beegle, Julie R, Magner, Nataly Lessa, Kalomoiris, Stefanos, Harding, Aja, Zhou, Ping, Nacey, Catherine, White, Jeannine Logan, Pepper, Karen, Gruenloh, William, Annett, Geralyn, Nolta, Jan A, Fierro, Fernando A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003097/ https://www.ncbi.nlm.nih.gov/pubmed/27610394 http://dx.doi.org/10.1038/mtm.2016.53 |
Ejemplares similares
-
Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models
por: Pollock, Kari, et al.
Publicado: (2016) -
Contribution of human hematopoietic stem cells to liver repair
por: Zhou, Ping, et al.
Publicado: (2009) -
Developing stem cell therapies for juvenile and adult-onset Huntington’s disease
por: Fink, Kyle D, et al.
Publicado: (2015) -
Human Myoblast and Mesenchymal Stem Cell Interactions Visualized by Videomicroscopy
por: Black, Amanda B., et al.
Publicado: (2015) -
Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells
por: Deng, Peter, et al.
Publicado: (2016)